Search Results - Nazem Atassi
- Showing 1 - 4 results of 4
-
1
Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants by Agnes Hincelin‐Mery, Xavier Nicolas, Cathy Cantalloube, Robert Pomponio, Pascale Lewanczyk, Myriam Benamor, Dimitry Ofengeim, Emmanuel Krupka, Jennifer Hsiao‐Nakamoto, Amy Eastenson, Nazem Atassi
Published in Clinical and Translational Science (2024-01-01)Get full text
Article -
2
Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis by Eva-Maria Ratai, Mohamad J. Alshikho, Nicole R. Zürcher, Marco L. Loggia, Catherine L. Cebulla, Paul Cernasov, Beverly Reynolds, Jennifer Fish, Raghav Seth, Suma Babu, Sabrina Paganoni, Jacob M. Hooker, Nazem Atassi
Published in NeuroImage: Clinical (2018-01-01)Get full text
Article -
3
Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosis by Robert L. Barry, Angel Torrado-Carvajal, John E. Kirsch, Grae E. Arabasz, Daniel S. Albrecht, Zeynab Alshelh, Olivia Pijanowski, Austin J. Lewis, Mackenzie Keegan, Beverly Reynolds, Paulina C. Knight, Erin J. Morrissey, Marco L. Loggia, Nazem Atassi, Jacob M. Hooker, Suma Babu
Published in NeuroImage: Clinical (2022-01-01)Get full text
Article -
4
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo‐controlled, double‐blind phase I/Ib... by Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld, Jerome Oude Nijhuis, Peter Paul De Deyn, Salah Hadi, Jeffrey Harris, Richard M. Tsai, Andres Cruz‐Herranz, Fen Huang, Vincent Tong, Rebecca Erickson, Yuda Zhu, Kimberly Scearce‐Levie, Jennifer Hsiao‐Nakamoto, Xinyan Tang, Megan Chang, Brian M. Fox, Anthony A. Estrada, Robert J. Pomponio, Miguel Alonso‐Alonso, Moshe Zilberstein, Nazem Atassi, Matthew D. Troyer, Carole Ho
Published in Clinical and Translational Science (2022-08-01)Get full text
Article
